Evidence map›Paper›PMID 39872393›Full record

ArticleLife medicine2024

Modeling antiviral response in the liver using human pluripotent stem cell-derived macrophages.

Yaxuan Zhang, Xingwu Zhang, Fuyu Duan, Huimin Qiao, Mingli Gong, Hui Qiu, Xia Chen, Peiliang Wang, Yuan He, Qiang Ding and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yaxuan ZhangCenter for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.ORCID https://orcid.org/0000-0002-2468-8896
Xingwu ZhangCenter for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.
Fuyu DuanCenter for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.
Huimin QiaoCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China.
Mingli GongCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China.
Hui QiuCenter for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.
Xia ChenCenter for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.
Peiliang WangCenter for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.
Yuan HeBoehringer Ingelheim-Tsinghua University Joint Research Center for Immuno-Infection, Tsinghua University, Beijing 100084, China.
Qiang DingCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China.
Jie NaCenter for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.ORCID https://orcid.org/0000-0003-1820-0548

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39872393
PMCPMC11749128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.